These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8001439)

  • 21. 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
    Konstas AG; Pikilidou MI; Tsironi S; Mikropoulos D; Kozobolis VP; Sarafidis PA; Lasaridis AN; Nelson LA; Stewart WC
    Curr Eye Res; 2009 May; 34(5):369-77. PubMed ID: 19401880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.
    Chiba T; Kashiwagi K; Chiba N; Tsukahara S
    Br J Ophthalmol; 2006 Mar; 90(3):314-7. PubMed ID: 16488953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC; Leland TM; Cate EA; Stewart JA
    J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle.
    Gwin RM; Gelatt KN; Gum GG; Peiffer RL
    Am J Vet Res; 1978 Jan; 39(1):83-6. PubMed ID: 629453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
    Alimgil ML; Erda S; Benian O
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma.
    Kerr CR; Hass I; Drance SM; Walters MB; Schulzer M
    Br J Ophthalmol; 1982 Feb; 66(2):109-14. PubMed ID: 7037047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical comparison of dipivalyl epinephrine and epinephrine in the treatment of glaucoma.
    Kohn AN; Moss AP; Hargett NA; Ritch R; Smith H; Podos SM
    Am J Ophthalmol; 1979 Feb; 87(2):196-201. PubMed ID: 373450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pilaren in the therapy of open-angle glaucoma].
    Erichev VP; Maĭchuk IuF
    Vestn Oftalmol; 1988; 104(5):16-9. PubMed ID: 3222825
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy and tolerance of dipivephrin].
    Sellem E; Cottier F; Chigot D
    Ophtalmologie; 1989; 3(3):223-4. PubMed ID: 2641116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD; McGuinness R
    Trans Ophthalmol Soc N Z; 1981; 33():27-9. PubMed ID: 7020221
    [No Abstract]   [Full Text] [Related]  

  • 35. Diurnal variations in intraocular pressure.
    Wilensky JT
    Trans Am Ophthalmol Soc; 1991; 89():757-90. PubMed ID: 1687295
    [No Abstract]   [Full Text] [Related]  

  • 36. Decrease of anterior ciliary arterial pressure with increased ocular pressure.
    Sakimoto G; Schwartz B
    Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):992-5. PubMed ID: 6746240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.
    Rossetti L; Barbieri P; Velati P; Bujtar E; Orzalesi N
    Graefes Arch Clin Exp Ophthalmol; 1994 Nov; 232(11):670-4. PubMed ID: 7843592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External ocular toxicity of dipivalyl epinephrine.
    Theodore J; Leibowitz HM
    Am J Ophthalmol; 1979 Dec; 88(6):1013-6. PubMed ID: 517603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epinephrine as the initial therapy in selected cases of ocular hypertension.
    Podos SM; Ritch R
    Surv Ophthalmol; 1980; 25(3):188-94. PubMed ID: 7466598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose response of topical pilocarpine-epinephrine combinations in normotensive and glaucomatous Beagles.
    Gelatt KN; Gum GG; Brooks DE; Wolf ED; Bromberg NM
    Am J Vet Res; 1983 Nov; 44(11):2018-27. PubMed ID: 6650955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.